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Abstract
The RNA interference (RNAi) method for targeted gene silencing is widely used in Caenorhabditis elegans for large-
scale functional genomic studies, analysis of limited gene sets and detailed analysis of individual gene function. The
application of RNAi has identified genes that participate in various aspects of development, physiology and cell
biology. In addition, RNAi has been used to identify interacting genes and to study functionally redundant genes.This
review discusses the various applications of RNAi in C. elegans, focusing particularly on the analysis of developmental
processes.
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INTRODUCTION
RNA interference (RNAi) is a process whereby the
introduction of double-strand (ds) RNA into cells or
tissues triggers degradation of cognate mRNA. As a
consequence of mRNA degradation, the corre-
sponding protein is depleted (‘knocked down’),
leading to defects associated with the loss of protein
function. In the literature, the term ‘RNAi’ is used
to describe both the laboratory method for silencing
gene expression and, often, the cellular mechanism
by which silencing occurs. RNAi is effective in many
contexts including cell culture and the analysis of
organisms not amenable to traditional genetic
analysis. In addition, major efforts are underway to
adapt RNAi for clinical applications in the treatment
of disease [1–3].
Thanks to intense research efforts over the last
decade or so, the core mechanism of RNAi is now
understood. This mechanism is briefly outlined here;
readers are referred to recent comprehensive reviews
for more details [1, 4]. Upon introduction into the
cell, dsRNA is cleaved by Dicer, a type III endo-
nuclease, into 21–23 nt small-interfering (si) RNAs.
SiRNA associates with the RNA-induced silencing
complex (RISC) and guides it to target mRNAs
that are then cleaved by RISC enzymatic activity.
The core component of RISC is an RNA-binding
protein of the Argonaute/PIWI/PAZ family; addi-
tional proteins are included in certain circumstances.
In Caenorhabditis elegans, as in plants and fungi, RNA-
directed RNA polymerase (RdRP) activity can
synthesize additional (secondary) siRNAs using the
target mRNA as template, thus amplifying the RNAi
response. RNAi is typically more robust in organisms
that contain an RdRP than in those that do not.
The above mechanism is part of a network of
interrelated cellular pathways that repress gene
expression at post-transcriptional and transcriptional
levels. Studies in many organisms have implicated
small non-coding RNA in the regulation of
chromatin structure, genome stability, mRNA
stability and mRNA translation [5–9]. The inter-
relationships among these mechanisms are not yet
clear. Best understood is the role of microRNA
(miRNA) in post-transcriptional gene silencing.
MiRNAs are 21–23 nt non-coding RNAs that base
pair with mRNA and either repress translation or
target the mRNAs for degradation [5, 6, 9]. Plant
miRNAs generally match their mRNA targets
perfectly and trigger mRNA degradation, whereas
most animal miRNAs base pair imperfectly and
block translation without apparently altering mRNA
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stability. MiRNAs are encoded by cellular genes,
production of mature miRNA relies on Dicer, and
the interaction of an miRNA with its target mRNA
involves an Argonaute protein. RNAi-related
mechanisms that rely on endogenous siRNAs have
been implicated in transposon silencing [10, 11] and
defence against infection by RNA viruses in a variety
of organisms [1, 6], and in meiotic silencing of
unpaired DNA in Neurospora crassa [12].
RNAi-related mechanisms participate in tran-
scriptional regulation by promoting formation of
repressive chromatin structures. In certain circum-
stances, DNA methylation and the accumulation of
specific histone modifications are directed by pro-
cesses that utilize components of the RNAi
machinery, including RdRP, Dicer, Argonaute
proteins and/or putative RNA helicases [7, 8]. At
present, the data suggest that small RNAs participate
in multiple chromatin regulatory mechanisms [e.g. in
Schizosaccharomyces pombe versus C. elegans versus
Drosophila; 13–15]. Non-coding RNAs are also
implicated in the process of DNA elimination
(chromosome diminution) in the macronucleus of
protists, such as Tetrahymena. Although the details of
this process are unclear, dsRNA has been shown to
trigger the loss of complementary DNA sequences in
a mechanism involving small non-coding RNA and
an Argonaute protein [16].
STRATEGIES FORUSING RNAI
ASATOOLTO STUDYGENE
FUNCTION
RNAi was first described in C. elegans [17, 18] in the
1990s and quickly became an important laboratory
tool for investigating gene function. While RNAi is
effective in many eukaryotes, C. elegans is particularly
amenable to RNAi, as dsRNA can be easily
administered and off-target effects are rare. More-
over, the availability of the genome sequence helped
to make RNAi the reverse genetic tool of choice,
particularly for genome-wide studies of develop-
mental processes. Meanwhile, the extensive genetic
tools available in C. elegans were used to analyse the
RNAimachinery itself. This approach eventually led to
the recovery ofmutant strains with an enhancedRNAi
response (an Eri phenotype) that greatly increased the
effectiveness of RNAi as a laboratory tool.
RNAi-based studies have now become an inte-
gral part of the effort to map genotype to phenotype
(see Figure 1). Although major efforts are under-
way to recover loss-of-function or null deletion
mutations in every C. elegans gene (The C. elegans
Knockout Consortium, http://celeganskoconsortium.
omrf.org/; National Bioresource Project, http://
shigen.lab.nig.ac.jp/c.elegans/index.jsp), the process
is cumbersome and it seems likely that several more
years of work are needed before the goal is met.
In contrast, (near) genome-wide RNAi has been
a reality for several years, and most genes have
been evaluated as to whether they are required
for viability or fertility. Researchers are identifying
components/regulators of specific biochemical
pathways and defined cellular/developmental pro-
cesses using both RNAi-based genome-wide surveys
and the analysis of candidate gene sets. ‘To facilitate
such goals, RNAi is often performed with a tester
strain that carries a visually tagged reporter transgene
or a weak mutation that sensitizes the genetic
background. The latter approach is especially useful
in studying essential genes whose function is required
for multiple aspects of development and, conversely,
in cases where RNAi-mediated knockdown in a
wild-type background does not produce visible
defects.
From the start, a major consideration in using
RNAi to study gene function has been how to
optimize the degradation of mRNA and, conse-
quently, protein knock-down. Genome-wide sur-
veys using wild-type animals observed visible defects
(inviability, sterility, gross alterations in body mor-
phology or movement) with RNAi directed against
10% of genes tested [19–22]; overall, this number is
50% less than what is expected based on analysis of
genetic mutants. Clearly, RNAi is less effective than
mutagenesis at disrupting gene expression. However,
RNAi is generally more effective at silencing gene
expression required for embryonic development
than for post-embryonic development. The detec-
tion of expected phenotypes increases 25% when
the tester strain carries a mutation in the rrf-3 gene
[23, 24] (see subsequently); detection of post-
embryonic phenotypes is particularly enhanced in
rrf-3 mutants. Although efforts have been made to
optimize the RNAi procedure, there apparently is
no overall optimal set of conditions, and the final
design of one’s RNAi-based assay depends on
technical considerations as well as the biological
question one wants to address. Fortunately, the rate
of false positives is very low (<1%) because off-target
effects are unusual. Technical considerations have
been discussed elsewhere [25–28] and will be
considered here only in brief.
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The primary considerations for RNAi in C.elegans
are (i) dsRNA delivery method, (ii) growth
temperature, (iii) the specific tester strain to use and
(iv) the developmental stage at which to treat. (i)
In vitro transcribed dsRNA can be injected into the
animal, animals can be soaked in a dsRNA solution
or animals can be fed bacteria that have been
engineered to express dsRNA. In these cases, the
dsRNA triggers a systemic RNAi response in most
tissues throughout the body. Some cells, notably
neurons, do not respond well to systemic RNAi. To
circumvent this problem, transgenic strains can be
generated that express hairpin (ds) RNA invivo in the
desired cells and tissues. Delivery by feeding is
generally the method of choice today (see subse-
quently). (ii) RNAi against many genes is more
effective at higher temperatures (e.g. 25C) than at
lower. However, 25C may not be optimal for
the desired tester strain. (iii) Sensitized genetic
backgrounds can facilitate the identification of
genes of interest. Mutations in genes such as rrf-3
(RNA-direct RNA polymerase family) and eri-1
(enhanced RNAi) produce an enhanced RNAi
response in many tissues [23, 29]; mutations in
components of the retinoblastoma pathway prefer-
entially enhance RNAi in nervous tissue [30]. A
drawback to using Eri strains is that many are
unhealthy, particularly at higher temperatures, and
thus may not be suitable for some screens. (iv)
Selective application of dsRNA during a specific
developmental stage can allow one to examine
the function of a gene that is active at multiple
developmental stages.
The systemic response to dsRNA delivered by
feeding or injection indicates that the C. elegans
intestine can export dsRNA (or siRNAs) and that
most C. elegans tissues can import dsRNA. Genetic
analysis has identified mutants that are specifically
defective in RNAi in response to feeding (i.e. they
respond to dsRNA delivered by injection or soaking)
[31]. These systemic RNA mutants presumably are
defective in the export, transport or import of
dsRNA, and their analysis should provide insight
into the mechanism(s) and biological function(s) of
cell-to-cell RNA transport.
ANALYSIS OF SPECIFIC
DEVELOPMENTALPROCESSES
ANDBIOCHEMICALPATHWAYS
USING LARGE-SCALE RNAI-BASED
SCREENS
RNAi-based screening has at least two advantages
compared with genetic screens: it provides a method
Figure 1: Strategy for analysis of gene function using RNAi. (A) Synchronized animals (P0 generation) are treated
with dsRNA by feeding, injection or soaking. Animals may be treated as larvae or adults. (B) P0 animals are assayed
for defects caused by degradation of targetmRNA. If P0 animals are treated at adult stage, then notable defectsmost
often involve the germ line. If P0 animals are treated at a larval stage, then various somatic defects may be observed
later in larval development and/or in adulthood. (C) The F1 generation is screened for developmental and other
abnormalities during embryonic and larval stages and in the adult. Early embryonic defects often arise from loss of
target mRNA that is maternally supplied to the oocytes. Target mRNA that is produced in the F1 generation is also
degraded, causing defects in embryonic and/or post-embryonic development, physiology and/or behaviour. See text
for details.
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for comprehensively assaying the genome; and one
immediately knows the molecular identity of each
positive gene. Most researchers who take the RNAi-
based approach have chosen to use a standardized
protocol where animals of the desired genotype are
provided with bacterial food sources that contain
dsRNA corresponding to the series of genes to be
tested [21, 32]. Large-scale surveys have also been
done by injecting in vitro transcribed dsRNAs
[20, 22] or soaking animals in dsRNA solution
[33]. However, as it is technically simpler to deliver
dsRNA by feeding, efforts were made to generate
libraries of bacterial ‘feeding’ plasmids that represent
each predicted gene [21] or a substantial portion of
expressed genes [34]. Many researchers have chosen
to use the commercially available library generated
by the Ahringer laboratory [21, 32].
Essentially, any assay that is amenable to genetic
screening can be adapted for use in an RNAi-based
screen. Details of the protocol depend on the tissue,
developmental stage and/or process one wants to
study. Initial genome-wide studies catalogued the
deleterious effects of RNAi on viability, fertility and
morphology during embryonic and larval develop-
ment [19–21, 33, 35, 36]. As RNAi-based surveys
became more common, more detailed sets of
phenotypic data were recorded, and subsequent
detailed surveys continued this trend [22, 24].
These data provide a general resource for analysis
of gene function and have been well discussed in
previous reviews [28]. This review will focus on
current trends, particularly the burgeoning use of
RNAi to carry out synthetic interaction (suppressor/
enhancer) screens and to examine gene interaction
networks.
General surveys
Many RNAi-based surveys have been conducted to
identify proteins whose knockdown causes specific
developmental or cellular defects. Such surveys have
identified proteins that regulate longevity/ageing
[37–42], fat metabolism [43], transposon silencing
[44], the DNA damage response [45], pronuclear
migration during fertilization [46], germ cell apop-
tosis [47], co-suppression [48], the nonsense-
mediated mRNA decay pathway [49], RNAi [50]
and those that protect against mutation [51]. Two
other recent studies that address the regulation of cell
migration and axon guidance are discussed here.
Cram et al. [52] identified proteins that
function in cell migration. The authors devised a
low-magnification visual screen for cell migration
defects based on displacement of the intestine, which
often reflects abnormal migration of the distal tip
cell, a somatic gonadal cell responsible for gonad
morphology; candidate migration defective animals
were then examined at high magnification using
differential interference contrast (DIC) optics to
identify those with distal tip cell migration defects.
It was suspected that cell migration would involve
genes essential for embryogenesis, thus RNAi was
performed by placing newly hatched (L1) larvae onto
feeding plates and screening for the migration defect
in late (L4) stage larvae or adults. In this way,
maternal effect lethality was avoided by treating
animals at a developmental stage when the maternal
product was no longer needed. Approximately 0.6%
of the genes tested (from a library representing 80%
of predicted open reading frames) were consistently
positive in the visual screen. The 99 gene products
fell into several different functional classes, and many
of them had not been previously implicated in the
regulation of cell migration (e.g. cell cycle regulators
and nucleic acid-binding proteins). To identify genes
that might participate in common regulatory
mechanisms, the authors combined their set of
migration-related genes and a pre-existing functional
interaction network constructed by Zhong and
Sternberg [53] to build a gene interaction network.
They constructed a network containing 59 of the
cell migration genes, within which are two sub-
clusters of genes implicated in (i) cell adhesion and
migration and (ii) tubulin interactions.
Schmitz et al. [54] sought to identify genes that
function in axon outgrowth. Because neurons tend
to be resistant to systemic RNAi, the authors first
isolated a mutant strain with an enhanced RNAi
response in neurons. This strain carried mutations in
two genes: lin-15B (previously identified as Eri by
Wang et al. [29]) and a gene that Schmitz and
colleagues named nre-1, for neuronal RNAi efficient.
They visualized axons with UNC-119::GFP expres-
sion and screened a set of 4600 genes (on
chromosomes I and III) for effects on axon guidance.
Consistent axonal guidance defects were associated
with RNAi-mediated knockdown of 2% of the
tested gene products; guidance defects were grouped
into several distinct classes. The guidance-associated
genes fell into a wide range of known/putative
functional classes, and many had not previously
been implicated in the regulation of neural
development.
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Synthetic interaction screens and
gene interaction networks
RNAi is potentially a powerful tool in the search for
gene interactions, and increasing numbers of such
surveys have been reported in the last few years. One
approach is to perform RNAi in a sensitized mutant
background as a means to identify genes whose
knockdown will either enhance or suppress a specific
phenotype of interest. A second approach is to search
more broadly for synthetic interactions as a means
to map gene interactions on a large (ultimately,
genome-wide) scale.
As an example of the former approach, Labbe
et al. [55] sought to identify factors that function in
establishing embryonic polarity. PAR (partitioning)
proteins were known to participate in the establish-
ment of anterior–posterior polarity during early
embryogenesis. Labbe et al. screened for suppression
of the embryonic lethality associated with loss of
par-2 function. They identified eight strong suppres-
sors of par-2 lethality and placed them into two
classes: regulators acting independently of PAR-2
(e.g. the Nanos family Zinc-finger protein, NOS-3)
and regulators acting via PAR-2 (e.g. the proteasome
regulatory subunit, RPN-12). The identity of certain
suppressors led the authors to revisit related genes
(which had not been strong suppressors in the
RNAi-based screen) and identify additional regula-
tors of PAR-2 activity. For example, two known
nos-3 co-regulators, FBF-1 and FBF-2, act redun-
dantly to regulate PAR-2 activity.
Parry et al. [56] devised an interaction screen to
identify components of the microRNA pathway.
The authors first demonstrated that the phenotype of
a weak mutation in the miRNA gene, let-7, could be
enhanced by knockdown of Dicer activity. Next,
they conducted a systematic screen for enhancement
of a let-7 developmental defect (vulval bursting) and
identified 213 candidate genes. Follow-up biochem-
ical and genetic studies ultimately identified a subset
of 44 new genes whose products function in the let-7
pathway. Among these were 19 general miRNA
pathway genes, most of which act downstream of
miRNA biogenesis. Analysis of these 19 genes
should provide insight into poorly understood
aspects of miRNA regulation and function, such as
how the miRNA–mRNA duplex is sensed and
ultimately how it represses translation.
In addition to identifying components of distinct
biochemical pathways or networks, synthetic inter-
action screens are also providing information about
genetic interactions on a genome-wide scale. Two
recent studies have taken a similar approach to
identifying synthetic interactions between known
developmental pathway components and a battery of
tester genes [57, 58]. Interaction data were used to
build gene interaction maps that revealed over-
arching patterns. It is not currently feasible to assay all
possible gene pairs; therefore, both studies by
necessity evaluated only a relatively small subset of
the possible interactions.
Lehner et al. [57] chose weak mutations in 31
‘query’ genes encoding components of EGF, Notch
and Wnt signalling pathways, several other cell
surface receptors and signalling components, and
several chromatin regulators. Mutants were cultured
on each of 1744 feeding ‘library’ bacterial RNAi
strains, and gene-x(mutant); gene-y(RNAi) animals
were visually scored for a range of phenotypes.
Three hundred and fifty pair-wise interactions
between query mutations and RNAi strains were
identified. Interaction mapping revealed that most
library genes, called ‘specific modulators’, interacted
with a single query gene. An exponentially smaller
number of library genes interacted with more than
one query gene, and a very few so-called ‘hub’ genes
interacted with many query genes representing
multiple signalling pathways. Lehner et al. hypothe-
sized that hub genes act to buffer development
against (minor) fluctuations in protein levels.
Interestingly, the six hub genes are all predicted to
encode chromatin proteins.
Byrne et al. [58] chose a set of 11 ‘query’ mutants
representing six cell-signalling pathways and 858
target genes; population growth was assayed as a
measure of genetic interaction. Genes were scored as
interacting if the population of gene-x(mutant); gene-
y(RNAi) animals grew more slowly than gene-
x(mutant) or gene-y(RNAi). This assay apparently
was more sensitive than that of Lehner et al.: among
1165 gene pairs tested in both studies, 78.5% were
negative in both, 1.5% were positive in both, 0.85%
were positive only for Lehner et al., and 19.1% were
positive only for Byrne et al. However, the overall
pattern of interactions was similar (many specific
modulators, few hub genes) and the two gene
interaction maps appear equally valid when compared
with other C. elegans interaction networks that are
based on protein interactions, gene expression pat-
terns, phenotypes and functional characteristics ([53,
59]; see WormBase, http://www.wormbase.org).
This approach provides information on multiple
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levels ranging from the organization of eukaryotic
genomes to the relationships among subsets of genes
that act in concert during development.
Numerous other large-scale gene interaction
screens have been performed. These include screens
designed to identify: modifiers of retinoblastoma
pathway activity [33], genes redundant with PTEN/
DAF-18 [60], modifiers of Unc-induced tau pheno-
type [61], regulators of lifespan [62], genes redundant
with the glycopeptide hormone-like receptor,
FSHR-1, in germ line development [63], regulators
of meiotic maturation [64], genes that are syntheti-
cally lethal in combination with loss of Ras-like
GTPase RAP-1 activity [65], genes that participate
redundantly with SynMuv A or B genes [66] or
antagonize SynMuv activity [67] to regulate vulval
development, synthetic lethality among candidate
targets of PAL-1 homeodomain protein activity [68],
negative regulators of the mitochondrial unfolded
protein response [69] and modifiers of the develop-
mental phenotype associated with reduced activity of
MUS-101 (mutagen sensitive), a protein implicated
in DNA stability [70]. Additional examples of the
gene interaction approach are included subsequently.
USING RNAI TO STUDY
TARGETED SETSOF GENES
Many researchers use RNAi to study subsets of genes
that have been identified via various critieria. It was
recognized early on that RNAi could target
individual members of repetitive gene families
whose members might be (at least partially) redun-
dant for function. RNAi can be extremely helpful
for assigning biological function to genes that have
been identified by various biochemical or molecular
criteria, such as candidate targets of transcription
factor activity identified by microarray analysis.
Illustrative examples of such studies are outlined
subsequently. For the purposes of this review, studies
are categorized as analysing redundant gene families,
candidate gene sets or tissue- or developmental-
stage-specific gene sets; however, there is clearly
some overlap among these categories.
Redundant gene families
Simonet et al. [71] addressed functional redundancy
among a set of 27 SET domain proteins to identify
those whose loss of function would enhance or
suppress developmental defects associated with
hpl-1 and hpl-2 mutations. The SET domain (initially
described in Drosophila suppressor of variegation,
enhancer of zeste and trithorax proteins) is char-
acteristic of histone methyltransferases and is required
for their enzymatic activity. HPL-1 and HPL-2 are
the two C. elegans members of the heterochromatin
protein 1 (HP1) family. HP1 proteins are implicated
in heterochromatin assembly and transcriptional
regulation (both positive and negative) in diverse
metazoan species. Simonet et al. demonstrated that
hpl-2 sterility was enhanced by knockdown of MET-
2 (methyltransferase), and the hpl-2 growth defect
was suppressed by knockdown of four other SET
domain proteins. Additional examples include the
analysis of 20 T-box family transcription factors [72]
and 129 putative RNA/DNA helicases [73]. A
particularly good example is provided by Lublin and
Evans [74]. This study identified the RNA-binding
protein, PUF-5 (Pumilio family) as a regulator
of maternal glp-1/Notch mRNA translation.
Caenorhabditis elegans has nine Pumilio-related RNA-
binding proteins. Using RNAi, the authors evaluated
the role of each PUF protein, and demonstrated that
PUF-5 and its closest family members, PUF-6 and
PUF-7, function redundantly during late oogenesis
to regulate expression of some (but not all) maternal
mRNAs.
Recently, Tischler et al. [75] developed a
combinatorial RNAi assay to address functional
redundancy on a genome-wide scale. Pairs of genes
were targeted by RNAi, and the resulting defects
were compared with those caused by RNAi targeted
against each single gene. A major concern in this
study was that dilution of feeding strain bacteria
would lead to false negatives, hence the authors
carefully tested for this effect. They estimated their
protocol as successfully detecting 50% of pair-wise
gene interactions. As a proof of concept, the authors
examined 143 sets of duplicated genes whose
Saccharomyces cerevisiae or D. melanogaster orthologues
are not duplicated. Combinatorial RNAi of 16 of
these gene sets revealed synergistic defects in brood
size and/or embryonic survival. Interestingly, 14/16
of these gene duplications are also present in
C. briggsae. Classically, one thinks of duplicated
genes as free to diverge in function, yet functional
redundancy of these 14 gene pairs has been (at least
partially) maintained for >80 million years since
C. elegans and C. briggsae diverged.
Candidate gene sets
Sieburth et al. [76] sought to identify genes required
for acetylcholine secretion using a candidate gene
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approach. They first chose a set of 2072 candidate
genes based on predicted function, such as involve-
ment in cell signalling or membrane trafficking,
localization to synapses or regulation of cytoskeletal
structure/function. Using the neuronal enhanced
RNAi strain, eri-1;lin-15B [30; see above], they tested
whether RNAi-mediated knockdown of any of the
2072 gene products rendered animals insensitive to
an acetylcholinesterase inhibitor, aldicarb. A second-
ary assay tested whether knockdown could suppress
the enhanced aldicarb sensitivity of dgk-1 (diacylgly-
cerol kinase) mutant animals. These assays identified
185 genes required for a normal level of acetylcho-
line secretion, of which 132 were not previously
known to influence synaptic transmission. In sub-
sequent studies, functional analysis of 60 genes
identified subsets whose products function in the
synaptic vesicle cycle or neuropeptide signalling.
Follow-up studies included determining the sub-
cellular localization pattern of 100 of the 132
proteins and further evaluating the role of 19 genes
in synapse formation/structure using genetic
mutants. This study greatly expanded the number
of proteins known to influence synaptic function,
and provides a rich resource for future studies.
In another example, Srayko et al. [77] built on
data accumulated in previous RNAi studies to select
a candidate list of genes that were known to
influence microtubule-associated processes and
might, therefore, function in microtubule nucleation
or growth. They developed a sensitive visual assay
based on distribution of an EBP-2::GFP transgenic
marker that normally labels the growing (plus) end of
microtubules. An RNAi-based survey of the candi-
date genes identified proteins whose function either
increased or decreased microtubule nucleation rate,
promoted microtubule growth or limited the retro-
grade movement of microtubule plus ends. One
interesting finding was that nucleation and growth
rate are regulated by largely independent sets of
proteins, suggesting these are independent processes.
Moreover, few proteins function to regulate micro-
tubule polymerization; the authors propose that,
instead, growth depends mainly on the availability of
tubulin subunits.
A number of studies examining other problems
have taken the same general approach as those above.
The sizes of the candidate gene sets vary widely.
Examples include analysis of: the role of predicted
transcription factors in regulation of vulval develop-
ment [78]; predicted kinases that may mediate the
response to oxidative stress [79]; proteins that localize
to the mid-body and may function in formation and
movement of the cleavage furrow [80]; candidate
targets of the DAF-16 transcriptional regulator [81];
candidate regulators of phosphatidylserine exposure
during apoptosis [82] and regulators of mRNA
translation during oogenesis [74].
Tissue- and developmental-stage-
enriched transcripts
RNAi can provide information as a complement to
biochemical, molecular and proteomic data. For
example, early gene expression profiling studies
identified genes whose transcripts are enriched in
the germ line relative to the soma [83, 84].
Colaiacovo et al. [85] searched these microarray data
to identify genes whose transcript pattern mirrored
that of known meiotic genes, and then used RNAi to
investigate as to which of these germ line-enriched
transcripts might, in fact, function in meiosis. Fifty-
two of 192 genes assayed (27%) were required for
aspects of meiosis and/or for other aspects of germ line
development, such as proliferation. Piano et al. [35]
took a related approach to identify genes required for
oogenesis and/or embryogenesis. Starting with a
(random) set of cDNAs made using adult ovarian
mRNA, they identified 81 genes as required for
embryonic viability; 36 of these genes were also
required for oogenesis. In a follow-up study, Piano
etal. [36] evaluated a much larger set of (750) genes
whose expression was described as ovary-enriched
based on microarray analysis. This study provided
information about gene expression trends in the germ
line (for example, X-linked genes are rarely expressed
in the germ line). Piano et al. [36] defined 47 patterns
of defective embryogenesis associated with RNAi-
mediated knockdown of different genes and grouped
these genes into ‘phenoclusters’ that might reflect
related gene functions. Later, Sonnichsen et al. [22]
applied a similar approach to classify a far larger set of
genes into phenoclusters based on a set of 23
embryonic phenotypes. Investigation of the relation-
ships among gene products in individual phenoclus-
ters should provide insight into developmental
processes during embryogenesis.
RNAI ASACOMPLEMENT TO
MUTATIONALANALYSIS
Caenorhabditis elegans researchers use RNAi to com-
plement mutational analysis in many contexts. As
described above in the context of RNAi-based
190 Maine
 at S
yracuse U
niversity on D
ecem
ber 17, 2010
bfg.oxfordjournals.org
D
ow
nloaded from
 
screens, focused analysis of a regulatory pathway or
developmental process can benefit from combining
RNAi with traditional genetic analysis. For example,
RNAi can silence gene expression at a specific
developmental stage (helpful in the absence of an
available temperature-sensitive allele) or be used in
combination with genetic mutations to simulta-
neously silence multiple gene products. In many
cases, gene-x(-)gene-y(RNAi) animals may be far easier
to generate than gene-x(-) gene-y(-) double mutants
[86]. Another common use of RNAi is in gene
cloning, particularly in tissues where DNA-mediated
transformation rescue is problematic (e.g. the germ
line). Once a gene of interest is mapped to a discrete
chromosomal interval, candidate genes located
within the interval can be assayed by RNAi to
identify any of those whose knockdown mimics the
mutant phenotype of the gene of interest [87].
Tissue-specific RNAi can also function as a sort of
poor man’s genetic mosaic analysis. In particular, rrf-1
(RNA-dependent RNA polymerase family) mutants
disrupt RNAi in the soma but not the germ line,
allowing one to distinguish between germ line and
somatic gene expression [88]. If dsRNA treatment of
wild-type animals produces a defect that does not arise
when rrf-1mutants are treated with the same dsRNA,
then the standard interpretation is that the defect
depends on gene silencing in the soma. This approach
has been used extensively to distinguish germ line
versus soma as the tissue site of action for many genes
that promote germ line development [e.g. 87, 89–94,
among others]. Similarly, comparative RNAi in wild-
type versus Rb pathway mutants may be useful for
distinguishing the tissue site of action for genes that
regulate development of specific neurons.
DATA ANALYSISAND STORAGE
As researchers have generated increasing amounts of
data from RNAi-mediated gene-silencing studies,
one challenge has been how to best store the data for
ease of retrieval and comparison. Data from many of
general RNAi surveys have been compiled in the
C. elegans online database, WormBase (http://
www.wormbase.org). WormBase includes the
following information: the phenotypic terms that
were scored; the results (positive and negative) and
the portion of each open reading frame used to
produce dsRNA. Piano and colleagues [35, 36]
developed an online repository of DIC photomicro-
graphs and time-lapse imagery of embryonic defects
called RNAi Database (http://nematoda.bio.
nyu.edu:8001/cgi-bin/index.cgi). A similar database
of germ line defects is now being assembled and will
be incorporated into RNAi Database ( J. Hubbard,
personal communication). Likewise, videomicro-
scopy data from Sonnichsen et al. [22] are available
online at Phenobank (http://www.worm.mpi-
cbg.de/phenobank2/cgi-bin/MenuPage.py). These
RNAi data complement other large-scale efforts to
characterize C. elegans biology, including: mRNA in
situ hybridization data (The Nematode Expression
Pattern Database, http://nematode.lab.nig.ac.jp/);
nematode anatomy and morphology (Wormatlas,
http://www.wormatlas.org/); mutant phenotypes
(Wormbase and The National Bioresource Project,
URL listed above) and gene expression profiling
(microarray) data (Wormbase; GermOnline, http://
www.germonline.org/index.html). See Piano et al.
[95] for an excellent discussion of the various global
approaches to the study of C. elegans biology and
compilation of C. elegans databases.
SUMMARY
RNAi-mediated gene silencing is a common tool for
the analysis of gene function in C. elegans, and often
used as a complement to mutational, molecular and
biochemical approaches. The RNAi approach has
provided information about numerous aspects of
development and cell/biochemical processes.
Increasingly, gene interaction data obtained via
RNAi surveys (alone or in combination with other
data) are providing material for the construction of
gene interaction networks.
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Key Points
 RNAi-mediated gene silencing is a versatilemethod for studying
gene function.
 RNAi-based gene interaction screens are identifying compo-
nents of known biochemical and cellular pathways.
 RNAi-based screens are identifying proteins that function in
defined developmental and cellular processes.
 RNAi-mediated gene silencing is providing information for the
assembly of gene interaction networks.
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